Geron Corp financial data

Symbol
GERN on Nasdaq, GERNW on OTC
Industry
Pharmaceutical Preparations
Location
919 East Hillsdale Boulevard, Suite 250, Foster City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
GERON CORPORATION (to 8/5/2005)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 331 % -26.9%
Return On Equity -67.5 % +3.89%
Return On Assets -45.5 % +6.13%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 605M shares +11.3%
Common Stock, Shares, Outstanding 545M shares +39.6%
Entity Public Float 1.39B USD +177%
Common Stock, Value, Issued 603K USD +11.3%
Weighted Average Number of Shares Outstanding, Basic 662M shares +14.3%
Weighted Average Number of Shares Outstanding, Diluted 662M shares +14.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 29.5M USD +9200%
General and Administrative Expense 83.3M USD +67.2%
Operating Income (Loss) -208M USD -14.5%
Net Income (Loss) Attributable to Parent -201M USD -15.1%
Earnings Per Share, Basic -0.31 USD/shares +11.4%
Earnings Per Share, Diluted -0.31 USD/shares +11.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 60.3M USD +96.5%
Accounts Receivable, after Allowance for Credit Loss, Current 28M USD
Inventory, Net 20.3M USD
Assets, Current 398M USD +18.8%
Property, Plant and Equipment, Net 1.6M USD +29.6%
Operating Lease, Right-of-Use Asset 3.06M USD -17.1%
Assets 445M USD +7.73%
Accounts Payable, Current 13.7M USD +0.37%
Employee-related Liabilities, Current 15.2M USD +40.1%
Accrued Liabilities, Current 36.5M USD -12.8%
Liabilities, Current 138M USD +54.3%
Operating Lease, Liability, Noncurrent 2.46M USD -22.7%
Liabilities 146M USD +32.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.02M USD
Retained Earnings (Accumulated Deficit) -1.75B USD -13%
Stockholders' Equity Attributable to Parent 292M USD +0.58%
Liabilities and Equity 445M USD +7.73%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -62.3M USD -34.3%
Net Cash Provided by (Used in) Financing Activities 148M USD -47.4%
Net Cash Provided by (Used in) Investing Activities 34.2M USD
Common Stock, Shares Authorized 1.35B shares 0%
Common Stock, Shares, Issued 545M shares +39.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 120M USD +114%
Deferred Tax Assets, Valuation Allowance 395M USD +13%
Deferred Tax Assets, Gross 396M USD +13%
Payments to Acquire Property, Plant, and Equipment 615K USD +65.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -199M USD -13.8%
Property, Plant and Equipment, Gross 2.41M USD +42.6%
Operating Lease, Liability, Current 968K USD +2.65%
Deferred Tax Assets, Operating Loss Carryforwards 272M USD +6.99%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Unrecognized Tax Benefits 26.3M USD +11%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1M USD -9.09%
Share-based Payment Arrangement, Expense 28.8M USD +76.8%
Interest Expense 12.1M USD +51.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%